Astellas Pharma Competitors and Similar CompaniesClear all
Astellas Pharma's competitors and similar companies include Pfizer, AbbVie, Bayer, Nipro Corporation, Immunomedics, Shionogi, Urovant Sciences, Hetero and Viatris.
 Astellas Pharma Astellas Pharma (アステラス製薬株式会社) is a pharmaceutical company focused on the development of drugs and medical solutions. |  Pfizer Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products. |  AbbVie AbbVie is a pharmaceutical company engaged in the research and development, manufacturing, commercialization, and sale medicines and therapies. |  Nipro Corporation Nipro Corporation (ニプロ株式会社) is a company that develops medical devices, pharmaceuticals, and pharma packaging. |  Immunomedics Immunomedics is a developer of monoclonal antibody-based products for the targeted treatment of cancer. |  Shionogi Shionogi (塩野義製薬株式会社) is a pharmaceutical company developing treatments for infectious, pain, and chronic liver diseases. |  Urovant Sciences Urovant Sciences is a biopharmaceutical company focused on developing novel therapies for urologic conditions. |  Hetero Hetero is a generic pharmaceutical company engaged in the development, manufacturing, and marketing of chemical and biologic drugs. |  Viatris Viatris is a pharmaceutical company that develops and manufactures branded and generic medicines, biosimilar medicines, and over-the-counter products. | ||
Founding Date | Founding Date 1923 | Founding Date 1849 | Founding Date 2013 | Founding Date 1863 | Founding Date 1954 | Founding Date 1982 | Founding Date 1878 | Founding Date 2016 | Founding Date 1993 | Founding Date 2020 |
Type | Type Public | Type Public | Type Public | Type Public | Type Public | Type Subsidiary | Type Public | Type Public | Type Private | Type Public |
Tags | ||||||||||
Locations | Locations Tokyo, JP HQ Macquarie Park, AU Wien, AT Vilvoorde, BE São Paulo, BR Markham, CA Beijing, CN see more | Locations New York, US HQ Buenos Aires, AR Villa Adelina, AR Bentley, AU Footscray, AU Mulgrave, AU Sydney, AU see more | Locations HQ | Locations Morris Plains, US HQ | Locations Osaka, JP HQ Beijing, CN Hong Kong, HK Amagasaki, JP Amagasaki, JP Kanegasaki, JP Misato, JP see more | Locations Irvine, US HQ Basel, CH | Locations Hyderabad, IN HQ Norwest, AU Sao Paulo, BR Beijing, CN Nanjing Shi, CN Nanjing Shi, CN Bogotá, CO see more | Locations Canonsburg, US HQ Carole Park, AU Millers Point, AU Campos Dos Goytacazes, BR São Paulo, BR Sofia, BG Toronto, CA see more | ||
Employees | Employees 14,484 | Employees 83,0005% increase | Employees 50,000 | Employees 100,8731% decrease | Employees 38,770 | Employees 1172% decrease | Employees 5,680 | Employees 3950% increase | Employees 21,000 | Employees 37,000 |
Valuation ($) | Valuation ($) 22 b | Valuation ($) 171.2 b | Valuation ($) 254.5 b | Valuation ($) 33.1 b | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 14 b | Valuation ($) 531.8 m | Valuation ($) N/A | Valuation ($) 11.2 b |
Twitter followers | Twitter followers 50.4 k | Twitter followers 491.8 k | Twitter followers 78.9 k | Twitter followers 184.4 k | Twitter followers N/A | Twitter followers 568 | Twitter followers N/A | Twitter followers 221 | Twitter followers 920 | Twitter followers 8.3 k |
Number of tweets (last 30 days) | Number of tweets (last 30 days) 25 | Number of tweets (last 30 days) 16 | Number of tweets (last 30 days) 52 | Number of tweets (last 30 days) 30 | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) 1 | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) 4 |
Average likes per tweet (last 30 days) | Average likes per tweet (last 30 days) 5.8 | Average likes per tweet (last 30 days) 63.4 | Average likes per tweet (last 30 days) 5.2 | Average likes per tweet (last 30 days) 10 | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) 3 | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) 9 |
Percentage of tweets with engagement (last 30 days) | Percentage of tweets with engagement (last 30 days) 96% | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) 88.46% | Percentage of tweets with engagement (last 30 days) 73.33% | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) 100% |
Employee Rating | Employee Rating 4.2 | Employee Rating 4.2 | Employee Rating 3.9 | Employee Rating 4.3 | Employee Rating 3.5 | Employee Rating 2.9 | Employee Rating 3.6 | Employee Rating 5 | Employee Rating 3.6 | Employee Rating 3.5 |
Financial | ||||||||||
Revenue (est.) | Revenue (est.) ¥1.5t (FY, 2023) | Revenue (est.) $100.3b (FY, 2022) | Revenue (est.) $58.1b (FY, 2022) | Revenue (est.) €50.7b (FY, 2022) | Revenue (est.) ¥442.5b (FY, 2020) | Revenue (est.) $295k (FY, 2019) | Revenue (est.) ¥426.7b (FY, 2023) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $16.3b (FY, 2022) |
Cost of goods | Cost of goods ¥182.6b (FY, 2023) | Cost of goods $34.3b (FY, 2022) | Cost of goods $17.4b (FY, 2022) | Cost of goods €11.9b (FY, 2022) | Cost of goods ¥308.3b (FY, 2020) | Cost of goods N/A | Cost of goods ¥49.2b (FY, 2023) | Cost of goods N/A | Cost of goods N/A | Cost of goods $9.8b (FY, 2022) |
Gross profit | Gross profit ¥1.3t (FY, 2023) | Gross profit $66b (FY, 2022) | Gross profit $40.6b (FY, 2022) | Gross profit €39.9b (FY, 2022) | Gross profit ¥134.2b (FY, 2020) | Gross profit $295k (FY, 2019) | Gross profit ¥378.9b (FY, 2023) | Gross profit N/A | Gross profit N/A | Gross profit $6.5b (FY, 2022) |
Net income | Net income ¥98.7b (FY, 2023) | Net income $31.4b (FY, 2022) | Net income $11.8b (FY, 2022) | Net income €4.2b (FY, 2022) | Net income (¥11.6b) (FY, 2020) | Net income ($357.3m) (FY, 2019) | Net income ¥184.5b (FY, 2023) | Net income ($146.7m) (FY, 2020) | Net income N/A | Net income $2.1b (FY, 2022) |
Operating ⚠ | ||||||||||
Countries | Countries N/A | Countries 125 (FY, 2021) | Countries 70 (FY, 2022) | Countries 83 (FY, 2021) | Countries N/A | Countries N/A | Countries N/A | Countries N/A | Countries 126 (Jan, 2021) | Countries 165 (Q1, 2023) |
Manufacturing Facilities | Manufacturing Facilities N/A | Manufacturing Facilities N/A | Manufacturing Facilities 19 (FY, 2022) | Manufacturing Facilities N/A | Manufacturing Facilities N/A | Manufacturing Facilities N/A | Manufacturing Facilities 4 (FY, 2018) | Manufacturing Facilities N/A | Manufacturing Facilities 36 (Jan, 2021) | Manufacturing Facilities N/A |
Manufacturing Sites | Manufacturing Sites N/A | Manufacturing Sites 39 (FY, 2021) | Manufacturing Sites N/A | Manufacturing Sites N/A | Manufacturing Sites N/A | Manufacturing Sites N/A | Manufacturing Sites N/A | Manufacturing Sites N/A | Manufacturing Sites N/A | Manufacturing Sites 40 (Q1, 2023) |
Patent Applications (US) | Patent Applications (US) N/A | Patent Applications (US) N/A | Patent Applications (US) N/A | Patent Applications (US) N/A | Patent Applications (US) N/A | Patent Applications (US) 230 (Sep, 2022) | Patent Applications (US) N/A | Patent Applications (US) N/A | Patent Applications (US) 23 (Jan, 2021) | Patent Applications (US) N/A |
Patents (US) | Patents (US) N/A | Patents (US) N/A | Patents (US) N/A | Patents (US) N/A | Patents (US) N/A | Patents (US) 405 (Sep, 2022) | Patents (US) N/A | Patents (US) N/A | Patents (US) 38 (Jan, 2021) | Patents (US) N/A |
Product Categories | Product Categories N/A | Product Categories N/A | Product Categories 6 (FY, 2022) | Product Categories N/A | Product Categories N/A | Product Categories N/A | Product Categories N/A | Product Categories N/A | Product Categories N/A | Product Categories 3 (Q1, 2023) |
Products | Products N/A | Products N/A | Products N/A | Products N/A | Products N/A | Products N/A | Products N/A | Products N/A | Products 200 (Jan, 2021) | Products 4 (FY, 2022) |
Funding | ||||||||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 3.5b | Total funding raised N/A | Total funding raised $ 30m | Total funding raised $ 4.7m | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Pfizer
HQ
New York, US
Employees
83,000↑ 5% increase
Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products.
View companyAbbVie
HQ
Lake Bluff, US
Employees
50,000
AbbVie is a pharmaceutical company engaged in the research and development, manufacturing, commercialization, and sale medicines and therapies.
View company
Bayer
HQ
Leverkusen, DE
Employees
100,873↓ 1% decrease
Bayer is a life sciences company specializing in healthcare and nutrition.
View companyNipro Corporation
HQ
Employees
38,770
Nipro Corporation (ニプロ株式会社) is a company that develops medical devices, pharmaceuticals, and pharma packaging.
View company